$1.08 -0.10 (-8.47%)
11/25/2009 3:59 PM

CombinatoRx, Inc. (CRXX)

CAPS Rating: 5 out of 5

A biopharmaceutical company pioneering the new field of synergistic combination pharmaceuticals, with a portfolio of product candidates in phase 2 clinical development.

Featured Broker Partners